Literature DB >> 16464908

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.

Nathan K LeBrasseur1, Meghan Kelly, Tsu-Shuen Tsao, Stephen R Farmer, Asish K Saha, Neil B Ruderman, Eva Tomas.   

Abstract

Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARgamma in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARgamma-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 microM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 microM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-d-glucose uptake and the oxidation of exogenous [(14)C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARgamma to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARgamma-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464908     DOI: 10.1152/ajpendo.00453.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  96 in total

1.  Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats.

Authors:  Heidi N Boyda; Ric M Procyshyn; Lurdes Tse; Erin Hawkes; Chen H Jin; Catherine C Y Pang; William G Honer; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.

Authors:  Ming Zhu; Lesley Flynt; Sanjukta Ghosh; Matt Mellema; Audreesh Banerjee; Erin Williams; Reynold A Panettieri; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

3.  Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.

Authors:  Bardia Askari; Jenny E Kanter; Ashley M Sherrid; Deidre L Golej; Andrew T Bender; Joey Liu; Willa A Hsueh; Joseph A Beavo; Rosalind A Coleman; Karin E Bornfeldt
Journal:  Diabetes       Date:  2007-01-26       Impact factor: 9.461

4.  Inulin increases glucose transport in C2C12 myotubes and HepG2 cells via activation of AMP-activated protein kinase and phosphatidylinositol 3-kinase pathways.

Authors:  Hee Yun; Jong Hwa Lee; Chang Eun Park; Min-Jung Kim; Byung-Il Min; Hyunsu Bae; Wonchae Choe; Insug Kang; Sung-Soo Kim; Joohun Ha
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

Review 5.  Regulation of pyruvate metabolism in metabolic-related diseases.

Authors:  Nam Ho Jeoung; Chris R Harris; Robert A Harris
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 6.  Obesity and lipodystrophy--where do the circles intersect?

Authors:  Farid F Chehab
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

Review 7.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

8.  Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization.

Authors:  Meghan Kelly; Marie-Soleil Gauthier; Asish K Saha; Neil B Ruderman
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

9.  Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gamma.

Authors:  Charles W Bolten; Patrick M Blanner; William G McDonald; Nicholas R Staten; Richard A Mazzarella; Graciela B Arhancet; Martin F Meier; David J Weiss; Patrick M Sullivan; Alexander E Hromockyj; Rolf F Kletzien; Jerry R Colca
Journal:  Gene Regul Syst Bio       Date:  2007-09-17

10.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation.

Authors:  Simon A Hawley; Fiona A Ross; Cyrille Chevtzoff; Kevin A Green; Ashleigh Evans; Sarah Fogarty; Mhairi C Towler; Laura J Brown; Oluseye A Ogunbayo; A Mark Evans; D Grahame Hardie
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.